BCM
MBVX
Biomark Capital Management’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $4K | Hold |
8,903
| – | – | 0.04% | 2 |
|
|
2018
Q2 | $8K | Hold |
8,903
| – | – | 0.12% | 2 |
|
|
2018
Q1 | $13K | Sell |
8,903
-17,805
| -67% | -$26K | 0.2% | 2 |
|
|
2017
Q4 | $19K | Hold |
26,708
| – | – | 0.02% | 3 |
|
|
2017
Q3 | $17K | Hold |
26,708
| – | – | 0.02% | 3 |
|
|
2017
Q2 | $37K | Hold |
26,708
| – | – | 0.06% | 3 |
|
|
2017
Q1 | $61K | Hold |
26,708
| – | – | 0.11% | 3 |
|
|
2016
Q4 | $90K | Hold |
26,708
| – | – | 0.19% | 3 |
|
|
2016
Q3 | $113K | Sell |
26,708
-170,933
| -86% | -$723K | 0.15% | 3 |
|
|
2016
Q2 | $119K | Hold |
197,641
| – | – | 0.15% | 3 |
|
|
2016
Q1 | $142K | Hold |
197,641
| – | – | 0.2% | 3 |
|
|
2015
Q4 | $136K | Buy |
+197,641
| New | +$136K | 0.17% | 3 |
|